OrbusNeich® Announces China Approval for COMBO® Coronary Stent-PR Newswire APAC

HONG KONG, Sept. 23, 2020 /PRNewswire/ -- OrbusNeich Medical Co. Ltd. has announced that the National Medical Products Administration (NMPA) has granted market approval for the COMBO BIO-ENGINEERED SIROLIMUS ELUTING STENT in China. It is the first dual therapy stent to both accelerate endothelial coverage and control neointimal proliferation...

Read more: OrbusNeich® Announces China Approval for COMBO® Coronary Stent-PR Newswire APAC

More Articles …

  1. Programmatic Pioneers Summit by WBR launches Asian chapter, to begin with free to attend virtual event-PR Newswire APAC
  2. Citi announces speaker line-up for Australia's largest Investment Conference-PR Newswire APAC
  3. New Consumer Goods Coalition to Accelerate Systemic Effort to Remove Deforestation and Forest Degradation from Key Commodity Supply Chains
  4. Argon & Co expands global presence into New Zealand-PR Newswire APAC
  5. ChannelAdvisor Announces Integration With Bunnings Marketlink-PR Newswire APAC
  6. RedShield Named 2021 TAG Cyber Distinguished Vendor-PR Newswire APAC
  7. Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market-PR Newswire APAC
  8. Saladplate to launch theme-based virtual Sourcing Festival for food & hospitality industry-PR Newswire APAC
  9. TEAM Software and Templa Join Forces to Strengthen Offerings to the UK and Australian Cleaning Markets-PR Newswire APAC
  10. Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma-PR Newswire APAC